Edition:
India

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

11.41USD
1:30am IST
Change (% chg)

$-0.12 (-1.04%)
Prev Close
$11.53
Open
$11.48
Day's High
$11.57
Day's Low
$11.25
Volume
30,191
Avg. Vol
45,485
52-wk High
$13.09
52-wk Low
$5.48

Cassella, James 

Dr. James V. Cassella Ph.D. serves as Chief Development Officer of the Company. He has served as our Chief Development Officer since February 2015. Prior to joining Concert, Dr. Cassella served as Executive Vice President, Research and Development and Chief Scientific Officer of Alexza Pharmaceuticals, Inc., a biotechnology company, from July 2012 to January 2015 and served as its Senior Vice President, Research and Development from 2004 to July 2012. From 1989 to 2004, Dr. Cassella held various management positions at Neurogen Corporation, a biotechnology company. Prior to Neurogen, Dr. Cassella was Assistant Professor of Neuroscience at Oberlin College. Dr. Cassella received a B.A. in Psychology from the University of New Haven and a Ph.D. in Physiological Psychology from Dartmouth College and completed a postdoctoral fellowship in the Department of Psychiatry at the Yale University School of Medicine.

Basic Compensation

Total Annual Compensation, USD 435,394
Restricted Stock Award, USD 319,397
Long-Term Incentive Plans, USD --
All Other, USD 940,248
Fiscal Year Total, USD 1,695,040

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

157,592

Roger Tung

2,772,350

Marc Becker

1,887,420

Nancy Stuart

1,908,030

James Cassella

1,695,040

Jeffrey Munsie

--
As Of  31 Dec 2019